Drug overdose mortality among healthcare system patients and publicly and privately insured people in North Carolina, USA: 2014–2022

Background The drug overdose epidemic—responsible for approximately 108 000 deaths in the USA in 2022 and imposing a substantial economic burden—underscores the need to better understand population-specific risks. We compared overdose mortality rates in North Carolina across three cohorts—healthcare system patients, privately insured individuals and Medicaid enrollees—from 2014 to 2022. Methods Data from large integrated datasets for populations of interest were linked with death certificate records for 2014–2022. Overdose deaths involving all-drug, opioids or polydrugs were identified using International Classification of Disease Version 10 codes for primary and contributing cause of death among individuals aged 12–64. Using North Carolina population as the reference, age-, sex- and calendar year-adjusted overdose mortality rates and standardised mortality ratios were respectively calculated through direct and indirect standardisation. Results In North Carolina general population, overdose mortality rates per 100 000 person-years for all-drug, opioids and polydrugs were 28.8, 25.0 and 18.0 respectively. Among healthcare system patients, the corresponding adjusted rates were substantially higher—105.2, 86.4 and 62.8 (standardised mortality ratios: 3.4, 3.2, 3.3). Medicaid enrollees also had elevated rates—85.4, 63.6 and 46.4 (standardised mortality ratios: 2.8, 2.4, 2.4). In contrast, privately insured individuals had lower rates—16.1, 12.3 and 8.6 (standardised mortality ratios: 0.5, 0.5, 0.5). Conclusions Individuals receiving care within the health system experienced the highest overdose mortality rates, followed by those with Medicaid coverage, with both exceeding rates observed among privately insured individuals. These findings highlight significant socioeconomic health inequalities that could benefit from targeted overdose prevention interventions among resource-limited populations.

Authors

Institutions

Publication Details

Journal
Injury Prevention
Published
2026-10-28
DOI
https://doi.org/10.1136/ip-2026-046226
Primary Topic
Opioid Use Disorder Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Drug overdose mortality among healthcare system patients and publicly and privately insured people in North Carolina, USA: 2014–2022

Raana Zakeri, Shabbar I. Ranapurwala, Bethany L. DiPrete, Naoko Fulcher et al.
2 links
Injury Prevention
Opioid Use Disorder Treatment
article

Drug overdose mortality among healthcare system patients and publicly and privately insured people in North Carolina, USA: 2014–2022

Raana Zakeri, Shabbar I. Ranapurwala, Bethany L. DiPrete, Naoko Fulcher, Brian Wells Pence, Vanessa Eve Miller, Matthew Turnure, Pasangi Perera, Hillary Mortensen, Grace Yeboah-Kodie
article en

Abstract

Background The drug overdose epidemic—responsible for approximately 108 000 deaths in the USA in 2022 and imposing a substantial economic burden—underscores the need to better understand population-specific risks. We compared overdose mortality rates in North Carolina across three cohorts—healthcare system patients, privately insured individuals and Medicaid enrollees—from 2014 to 2022. Methods Data from large integrated datasets for populations of interest were linked with death certificate records for 2014–2022. Overdose deaths involving all-drug, opioids or polydrugs were identified using International Classification of Disease Version 10 codes for primary and contributing cause of death among individuals aged 12–64. Using North Carolina population as the reference, age-, sex- and calendar year-adjusted overdose mortality rates and standardised mortality ratios were respectively calculated through direct and indirect standardisation. Results In North Carolina general population, overdose mortality rates per 100 000 person-years for all-drug, opioids and polydrugs were 28.8, 25.0 and 18.0 respectively. Among healthcare system patients, the corresponding adjusted rates were substantially higher—105.2, 86.4 and 62.8 (standardised mortality ratios: 3.4, 3.2, 3.3). Medicaid enrollees also had elevated rates—85.4, 63.6 and 46.4 (standardised mortality ratios: 2.8, 2.4, 2.4). In contrast, privately insured individuals had lower rates—16.1, 12.3 and 8.6 (standardised mortality ratios: 0.5, 0.5, 0.5). Conclusions Individuals receiving care within the health system experienced the highest overdose mortality rates, followed by those with Medicaid coverage, with both exceeding rates observed among privately insured individuals. These findings highlight significant socioeconomic health inequalities that could benefit from targeted overdose prevention interventions among resource-limited populations.

Injury Prevention
University of North Carolina at Chapel Hill (US)
National Center for Injury Prevention and Control
Good health and well-being
Openalex Percentile: Top 10%
Opioid Use Disorder Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon